Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target?

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 9, 2009, Pages 3163-3170

  Van Den Berghe, Greet ^a   Schetz, Miet ^a   Vlasselaers, Dirk ^a   Hermans, Greet ^a   Wilmer, Alexander ^a   Bouillon, Roger ^a   Mesotten, Dieter ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CRITICALLY ILL PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; INTENSIVE CARE UNIT; PRIORITY JOURNAL; REVIEW; CRITICAL ILLNESS; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL;

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; INSULIN; INTENSIVE CARE UNITS; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 69949107080     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0663     Document Type: Article

References (41)

1. Mizock BA 1995 Alterations in carbohydrate metabolism during stress: a review of the literature. Am J Med 98:75-84
2. Bagshaw SM, Egi M, George C, Bellomo R; for the ANZICS Database Management Committee 2009 Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 37:463-470
3. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM 2005 Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111:3078-3086 (Pubitemid 40847785)
4. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, Raskin P 2008 Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117:1610-1619
5. Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L, Jones PG, Fiske S, Spertus JA 2009 Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169:438-446
6. Sinnaeve PR, Steg PG, Fox KA, Van de Werf F, Montalescot G, Granger CB, Knobel E, Anderson FA, Dabbous OH, Avezum A; GRACE Investigators 2009 Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Arch Intern Med 169:402-409
7. Van den Berghe G 2004 How does blood glucose control with insulin save lives in intensive care? J Clin Invest 114:1187-1195
8. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367 (Pubitemid 34940724)
9. McCowen KC, Friel C, Sternberg J, Chan S, Forse RA, Burke PA, Bistrian BR 2000 Hypocaloric total parenteral nutrition: effectiveness in prevention of hyperglycemia and infectious complications - a randomized clinical trial. Crit Care Med 28:3606-3611 (Pubitemid 30948998)
10. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G 2003 Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 88:1082-1088 (Pubitemid 36337759)
11. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G 2004 Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89:219-226 (Pubitemid 38183885)
12. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Vanden Berghe G 2005 Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 115:2277-2286 (Pubitemid 41134169)
13. Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F, Bouillon R, Schetz M 2006 Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 55:3151-3159 (Pubitemid 44923655)
14. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G 2005 Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365:53-59 (Pubitemid 40082146)
15. Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, Vanden Berghe G 2009 Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 37:1355-1364
16. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R 2006 Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461 (Pubitemid 43200296)
17. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G 2008 Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 19:571-578 (Pubitemid 351355400)
18. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet) 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139
19. Devos P, Preiser J, Melot C 2007 Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the glucontrol study. Proc 20th Annual Congress of European Society of Intensive Care Medicine (Abstract 0735). Intensive Care Med 33(Suppl 2):S189
20. Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH 2008 Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36:3190-3197
21. De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA; Grupo de Investigacion en Cuidado intensivo: GICI-HPTU 2008 Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 12:R120
22. Krinsley JS 2004 Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992-1000
23. Lecomte P, Foubert L, Nobels F, Coddens J, Nollet G, Casselman F, Crombrugge PV, Vandenbroucke G, Cammu G 2008 Dynamic tight glycemic control during and after cardiac surgery is effective, feasible, and safe. Anesth Analg 107:51-58
24. Lecomte P, Van Vlem B, Coddens J, Cammu G, Nollet G, Nobels F, Vanermen H, Foubert L 2008 Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care 12:R154
25. Furnary AP, Cheek DB, Holmes SC, Howell WL, Kelly SP 2006 Achieving tight glycemic control in the operating room: lessons learned from 12 years in the trenches of a paradigm shift in anesthetic care. Semin Thorac Cardiovasc Surg 18:339-345
26. Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A, Dhaliwal R, Henderson WR, Chittock DR, Finfer S, Talmor D 2009 Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180:821-827
27. Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ 2009 Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
28. Van den Berghe G, Mesotten D, Vanhorebeek I 2009 Intensive insulin therapy in the intensive care unit. CMAJ 180:799-800
29. Scott MG, Bruns DE, Boyd JC, Sacks DB 2009 Tight glucose control in the intensive care unit: are glucose meters up to the task? Clin Chem 55:18-20
30. Vlasselaers D, Van Herpe T, Milants I, Eerdekens M, Wouters PJ, De Moor B, Van den Berghe G 2008 Blood Glucose Measurements in Arterial Blood of Intensive Care Unit Patients Submitted to Tight Glycemic Control: Agreement between Bedside Tests. J Diabetes Sci Technol 2:932-938
31. Kanji S, Buffie J, Hutton B, Bunting PS, Singh A, McDonald K, Fergusson D, McIntyre LA, Hebert PC 2005 Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med 33:2778-2785 (Pubitemid 41816412)
32. Krinsley JS 2008 Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36:3008-3013
33. Hirsch IB, Brownlee M 2005 Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 19:178-181
34. Ceriello A, Ihnat MA, Thorpe JE 2009 Clinical review 2: the "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab 94:410-415
35. The Diabetes Control and Complications Trial Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
36. UK Prospective Diabetes Study (UKPDS) Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865 (Pubitemid 28416719)
37. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853 (Pubitemid 28416718)
38. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572 (Pubitemid 351831357)
39. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT 2008 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559
40. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators 2009 Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129-139
41. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G 2009 Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet 373:547-556